How many insider declarations has Young Wendy B. filed?

Young Wendy B. has filed 2 public insider declarations with SEC (Form 4).

What is Young Wendy B.'s role?

Young Wendy B.'s reported role is not specified by the regulator across the filings.

Which companies does Young Wendy B. report trades for?

Young Wendy B. reports trades for Rapport Therapeutics, Inc..

What is Young Wendy B.'s declared buy vs sell volume?

Across the available history, declared buys total 124k€ and disposals 0.

← Executives ★ Sign in to follow

YW

Young Wendy B.

OFFICER

·SEC (Form 4)

Rapport Therapeutics, Inc.

0

申报总数

0

公司

€123,526

▲ 买入（2 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

2

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Explore the full record of transactions filed by Young Wendy B.. Insider active across 1 company, notably Rapport Therapeutics, Inc.. Aggregated, 2 reports have been logged. Split: 2 buys · 0 sell. Total volume traded: €124k. Activity tracked since 12 March 2025. The latest transaction was disclosed on 11 September 2025 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.

Companies and markets linked to Young Wendy B.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Rapport Therapeutics, Inc. (US)

申报2 总计

▲

Young Wendy B.

Director高管2025年9月11日Rapport Therapeutics, Inc.

US$79,1000SEC ↗

3,500 股@ US$22.60Common StockSEC:0000950170-25-114325:0

标准退出：2025年12月10日 (T+90)

▲

Young Wendy B.

Director高管2025年3月12日Rapport Therapeutics, Inc.

US$61,25035SEC ↗

6,000 股@ US$10.2083100.0% 占其流量Common StockSEC:0000950170-25-038855:0

标准退出：2025年6月10日 (T+90)

2 条申报中的 2 条

InsidersTradesSigma

← Executives ★ Sign in to follow

YW

Young Wendy B.

OFFICER

·SEC (Form 4)

Rapport Therapeutics, Inc.

0

申报总数

0

公司

€123,526

▲ 买入（2 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

2

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Explore the full record of transactions filed by Young Wendy B.. Insider active across 1 company, notably Rapport Therapeutics, Inc.. Aggregated, 2 reports have been logged. Split: 2 buys · 0 sell. Total volume traded: €124k. Activity tracked since 12 March 2025. The latest transaction was disclosed on 11 September 2025 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.

Companies and markets linked to Young Wendy B.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Rapport Therapeutics, Inc. (US)

申报2 总计

▲

Young Wendy B.

Director高管2025年9月11日Rapport Therapeutics, Inc.

US$79,1000SEC ↗

3,500 股@ US$22.60Common StockSEC:0000950170-25-114325:0

标准退出：2025年12月10日 (T+90)

▲

Young Wendy B.

Director高管2025年3月12日Rapport Therapeutics, Inc.

US$61,25035SEC ↗

6,000 股@ US$10.2083100.0% 占其流量Common StockSEC:0000950170-25-038855:0

标准退出：2025年6月10日 (T+90)

2 条申报中的 2 条

Young Wendy B.

内部人交易记录

Companies and markets linked to Young Wendy B.

Related entities

Young Wendy B.

内部人交易记录

Companies and markets linked to Young Wendy B.

Related entities